News summary
xingqi eye medicinefreewhiterabbitslot: At 0freewhiterabbitslotAfter the approval of.01% atropine sulfate eye drops, the production line will produce uninterrupted 24 hours a day. Securities Times e Company News, Xingqi Eye Medicine (300573) recently stated in an institutional conference call that at 0freewhiterabbitslot.01% Atropine Sulfate Eye Drops was approved, the production line started for 24 hours...
Newsletter text
Xingqi Eye Drops: After the approval of 0.01% Atropine Sulfate Eye Drops, the production line will produce uninterrupted 24 hours a day. Securities Times e Company News, Xingqi Eye Drops (300573) recently stated in an institutional conference call that after the approval of 0.01% Atropine Sulfate Eye Drops, the production line will start uninterrupted 24 hours a day to meet the product requirementsfreewhiterabbitslotDue to the market demand, the production line is currently running smoothly and production is continuing in compliance. Recently, products produced by the company's new production lines have been put on the market one after another. In the future, the company will plan and expand production capacity in advance based on changes in market demand to fully meet market demand.
